Company Analysis

Tilray Brands, Inc. (TLRY)

Nasdaq: TLRY · Medicinal Chemicals & Botanical Products · New York, NY · filing with the SEC since 2018
Grade5.0
◀ Past 3.9● Present 5.9▶ Future 4.7
1 est.

Who runs Tilray Brands, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Simon Irwin D
President and CEO. First filing May 2021, latest Aug 27, 2026, 2 filings in all.
Officers reporting now
4
of 10 people with a filing in the last fifteen months
Directors reporting now
6
25 people on the record since 2018
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Simon Irwin DPresident and CEOMay 2021Aug 27, 2026none
Merton Carl AChief Financial OfficerApr 2021Aug 27, 2026none
Faltischek Denise MChief Strategy OfficerMay 2021Aug 27, 2026none
Gendel MitchellGlobal General CounselJul 2021Aug 27, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Clanachan David FdirectorMay 2021Jul 30, 2026none
Cohen Steven MichaeldirectorDec 2024Jul 30, 2026none
Herhalt Johann MichaeldirectorMay 2021Jul 30, 2026none
Hopkinson David G.directorMay 2021Jul 30, 20261 · $200,000
Looney Thomas P.directorApr 2021Jul 30, 2026none
Persofsky RenahdirectorApr 2021Jul 30, 2026none
Earlier names on the record16, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TLRY · research, not advice